Sign in to view content

Improvement of Worsening in Diabetic Retinopathy Through 2 Years in a Randomized Trial

Susan B. Bressler, MD, FASRS

Video
Published 2017

Related

Benefits and Value of Treatment for Diabetic Macular Edema
Paul Hahn, MD, PhD, FASRS
Updates from the Field
2022
Effect of Adjuvant Topical Dorzolamide-Timolol Versus Placebo in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial
Jason Hsu, MD
On Demand Cases, Courses, and Papers
2020
Long-Term Outcome of Diabetic Eyes With Vitreous Hemorrhage in an Urban Safety-Net Hospital
Hossein Ameri, MD, PhD, FRCSI, MRCOphth
Annual Meeting Talks
2024

Category: Diabetic Retinopathy

See more